Together, these findings demonstrate that both cannabinoid-based combinations restore glucose homeostasis and normalize plasma GLP-1 levels, while CSA + CBD additionally enhances colonic GLP-1, suggesting potential benefits for gut integrity and metabolic regulation in chronic colitis. The gene discussed is GLP1R; the disease is Chronic colitis.